REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER [ 2018 - 2022 ]

Research Grant

Researchers: A/Pr Pilar Blancafort (Principal investigator) ,  A/Pr Andrew Redfern ,  A/Pr Killugudi Swaminatha-Iyer ,  Dr Christine Chaffer ,  Prof Erik Thompson

Brief description Cancer cell spread around the body involves changes in the cells which allow them to migrate into blood vessels, travel and then invade other organs, a process called epithelial mesenchymal transition (EMT). EMT also makes cells less sensitive to our best treatments. EMT involves switching on genes that activate these changes and switching off genes that silence them. We will develop therapy that will reverse this process, both reducing cancer spread and making cancer treatment more effective.

Funding Amount $AUD 1,352,322.32

Funding Scheme Project Grants

Notes Standard Project Grant